EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Tardive dyskinesia in a patient treated with quetiapine



Tardive dyskinesia in a patient treated with quetiapine



World Journal of Biological Psychiatry 10(1): 54-57



Quetiapine is an atypical antipsychotic that is believed to have a low D2 binding affinity in striatal and extrastriatal regions. We report the case of a female patient with the diagnosis of schizoaffective disorder (using DSM-IV-TR criteria) who initially received amisulpride for 3 months, discontinued gradually because of persistent and distressing extra-pyramidal symptoms, and who developed tardive dyskinesia 3 months later after the initiation of quetiapine. A trial with ziprasidone resulted in a further worsening of tardive dyskinesia symptoms. A further trial with aripiprazole, improved her tardive dyskinesia symptoms. Although, it is under consideration the possibility that the improvement could have been due to the discontinuation of quetiapine, we conclude that aripiprazole improved the TD symptoms.

(PDF emailed within 0-6 h: $19.90)

Accession: 056116332

Download citation: RISBibTeXText

PMID: 19673087

DOI: 10.1080/15622970701362550



Related references

Remission of severe tardive dyskinesia in a schizophrenic patient treated with the atypical antipsychotic substance quetiapine. International Clinical Psychopharmacology 15(1): 57-60, 2000

Aripiprazole-induced tardive dyskinesia treated with quetiapine: a case report. Acta Neuropsychiatrica 23(4): 188-190, 2011

Olanzapine induced tardive dyskinesia treated successfully with quetiapine: a case report. Progress in Neuro-Psychopharmacology & Biological Psychiatry 35(1): 276-277, 2011

Adjunctive quetiapine decreases symptoms of tardive dyskinesia in a patient taking risperidone. Clinical Neuropharmacology 26(6): 297-298, 2003

Multi-segmental late onset idiopathic dystonia presenting as tardive dyskinesia and treated with quetiapine. European Neuropsychopharmacology 13(Supplement 4): S387-S388, September, 2003

Early-onset tardive dyskinesia in a neuroleptic-naive patient exposed to low-dose quetiapine. Movement Disorders 26(12): 2297-2298, 2012

Successful Management of Tardive Dyskinesia with Quetiapine and Clonazepam in a Patient of Schizophrenia with Type 2 Diabetes Mellitus. Clinical Psychopharmacology and Neuroscience 14(2): 218-220, 2016

Late-onset Quetiapine-related Tardive Dyskinesia Side Effects in a Patient with Psychotic Depression. Clinical Psychopharmacology and Neuroscience 12(2): 163-165, 2014

Rapid remission of severe tardive dyskinesia and tardive dystonia with quetiapine. International Journal of Geriatric Psychiatry 20(3): 287-288, 2005

Tardive dyskinesia with quetiapine. American Journal of Psychiatry 156(5): 796-797, 1999

Quetiapine in tardive dyskinesia. International Journal of Psychiatry in Clinical Practice 6(3): 175-177, 2002

Utility of quetiapine in tardive dyskinesia. Actas Espanolas de Psiquiatria 31(6): 347-352, 2003

Quetiapine-related tardive dyskinesia. American Journal of Psychiatry 158(10): 1737-1737, 2001

Reduction of tardive dyskinesia with quetiapine. Schizophrenia Research 47(2-3): 309-310, 2001

Tardive dyskinesia in an autistic patient treated with risperidone. American Journal of Psychiatry 161(4): 757-758, 2004